by Encapsulate | Nov 19, 2024 | Capitalization, Encapsulate Updates
Encapsulate Closes $1.8M Oversubscribed Seed Round to Accelerate Personalized Cancer Therapy Farmington, CT – Encapsulate, a developer of personalized oncology solutions, has raised $1.8 million in seed funding, led by Blackwood Healthcare Breakthroughs, Ambit Health...
by Encapsulate | Nov 18, 2024 | Awards, Encapsulate Updates
We are thrilled to announce that Encapsulate has secured 2nd place and a $75,000 cash prize at the 2024 Entrepreneurship World Cup Global Finals!Competing among the top 100 startups from 52 countries, Encapsulate was recognized for our advanced tumor-on-a-chip...
by Encapsulate | Aug 1, 2024 | Science
We are thrilled that we have presented at the ISSRDC conference in Boston with our groundbreaking study: “Encapsulate: Automated Biochips for Personalized Cancer Screening in Microgravity”.For the first time, we’ll be sharing the incredible data...
by Encapsulate | Jul 19, 2024 | Awards, Encapsulate Updates
HARTFORD–U.S. Senator Chris Murphy (D-Conn.) announced on Friday that Encapsulate, a Farmington-based medtech company founded by two UConn graduates, was named “Innovator of the Month” for their development of a transformative contribution to cancer treatment....
by Encapsulate | Mar 21, 2024 | Encapsulate Updates, Science
Yesterday marked a pivotal moment as we witnessed the launch of our cargo destined for the International Space Station, advancing our mission in cancer therapy.On Thursday, March 21 at 4:55 p.m. ET, Falcon 9 launched Dragon’s CRS-30 to the International Space Station...
